Medical devices, healthcare technology and the business of care
510(k) clearance · K261234

The D-Tip Denudation Pipette

Allwin Medical Devices, Inc. · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK261234

What did the FDA decide?

FDA recorded a substantially equivalent decision for The D-Tip Denudation Pipette, submitted by Allwin Medical Devices, Inc. of Anaheim, California, under 510(k) number K261234. The decision date is 09 October 2026, and the application was received 15 April 2026. The device falls under product code MQH, classified as microtools for assisted reproduction (pipettes), regulation number 884.6130, with a review panel and medical specialty of Obstetrics/Gynecology. The filing is a traditional 510(k), was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan.

Substantially equivalent means FDA cleared the submission for marketing; it is not premarket approval of a new device. The record does not describe the pipette's design, materials, intended clinical use, or the predicate device it was compared against, and no summary statement is present in the supplied data. The RSS listing independently confirms the same decision and applicant on the same date. Any reading of clinical role or comparative performance would require the underlying FDA documents, which are not included here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Obstetrics/Gynecology
Decision date
Oct 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261234
Regulatory pathway
510(k) premarket notification
Product code
MQH
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Microtools, Assisted Reproduction (Pipettes).

Product code
MQH
FDA device class
2

FDA decision timeline

  1. K261234 received

    Application receipt date recorded by FDA.

  2. K261234 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Allwin Medical Devices, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Anaheim, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records